RxDoctor Payments DataLook up a doctor →

Charles Caplis, DPM

Foot Surgery · Ocean Springs, MSNPI 1841483666

Payments from drug & device makers

$9,176in general payments, 2019–2025

Across 390 payments — averaging $23.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$3K
  • Amgen$1K
  • Convatec Inc.$985
  • Stryker$737
  • Paratek Pharmaceuticals, Inc.$394
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$346
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$8,17189%
  • Education$1051%
  • Other$90010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few foot surgery providers in Mississippito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$373,771
Medicare patients
911
Services billed
3,449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole14$10,355
Mupirocin146$1,713
Ketoconazole62$1,530
Doxycycline Hyclate113$1,300
Gabapentin76$1,059
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip36$908
Colchicine16$596
Pregabalin13$419
Clindamycin Hcl35$325
Methylprednisolone47$287
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$224
Cephalexin12$112
Ibuprofen19$79
Levofloxacin15$63

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$346$10,35514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few foot surgery providers in Mississippion file to place this against a meaningful peer group, so we don't.

Other foot surgery in Ocean Springs

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →